Who owns Core Scientific (CORZ)?
135 holders named in SEC filings declare between 95.8% and 119.2% of Core Scientific's shares outstanding, as of Sep 28, 2026. The largest are Vanguard (10.9%), BlackRock (8.8%) and Situational Awareness LP (8.1%); the five largest hold 41.3% together. Another 280 institutions hold small positions worth 2.8%. From Mar 31, 2026 to Jun 30, 2026, institutions that filed both quarters bought 28.8% and sold 29.1% of the shares, a net sale of 0.31%; 78 opened a position, 134 added, 123 reduced and 61 sold out. Biggest buyers: Jericho Capital Asset Management L.P. (+11.2M shares) and Jane Street (+6.4M shares). Biggest sellers: Pentwater Capital Management LP (-24.3M) and UBS (-9.6M). Schedule 13D/G filings since Mar 31, 2026: Kenneth Griffin crossed 5% (6.5%) on Jul 29, 2026, JANE STREET GROUP, LLC cut its stake to 6.3% on Jun 30, 2026, Jericho Capital Asset Management L.P. crossed 5% (7.1%) on Jun 30, 2026 and Pentwater Capital Management LP fell below 5% (0.42% still declared) on Jun 30, 2026. Directors and officers, from their latest Form 4: Adam Taylor Sullivan (1.4%). Over time, 401 managers declared Core Scientific in their 13F for Q2 2026, against 100 for Q1 2024: together at most 115.3% of the shares outstanding, against 28.7%.
| Holder | Filing | Share of capital | As of | Holding since (13F) |
|---|---|---|---|---|
| Vanguard | 13F | 10.9% | Jun 30, 2026 | Q1 2024 |
| BlackRock | 13F | 8.8% | Jun 30, 2026 | Q1 2024 |
| Situational Awareness LP | 13F | 8.1% | Jun 30, 2026 | Q1 2025 |
| Jericho Capital Asset Management L.P. | 13F | 7.1% | Jun 30, 2026 | Q3 2025 |
| Citadel | 13G | 6.5% | Jul 29, 2026 | — |
| UBS | 13F | 5.1% | Jun 30, 2026 | Q1 2024 |
| Two Sigma | 13F | 3.2% | Jun 30, 2026 | Q3 2024 |
| Value Aligned Research Advisors, LLC | 13F | 2.9% | Jun 30, 2026 | Q4 2025 |
| Two Seas Capital LP | 13F | 2.8% | Jun 30, 2026 | Q1 2024 |
| Geode Capital | 13F | 2.6% | Jun 30, 2026 | Q1 2024 |
| State Street | 13F | 2.4% | Jun 30, 2026 | Q2 2024 |
| Valiant Capital Management, L.P. | 13F | 2.3% | Jun 30, 2026 | Q2 2024 |
| Ascentis Wealth Management, LLC | 13F | 2.3% | Jun 30, 2026 | Q3 2024 |
| Jane Street | 13F | 2.0% | Jun 30, 2026 | Q4 2025 |
| Morgan Stanley | 13F | 2.0% | Jun 30, 2026 | Q1 2024 |
| T. Rowe Price | 13F | 1.9% | Jun 30, 2026 | Q2 2024 |
| ALLIANCEBERNSTEIN L.P. | 13F | 1.7% | Jun 30, 2026 | Q2 2024 |
| JPMorgan | 13F | 1.7% | Jun 30, 2026 | Q1 2024 |
| OAKTREE CAPITAL MANAGEMENT LP | 13F | 1.6% | Jun 30, 2026 | Q3 2025 |
| Monarch Alternative Capital LP | 13F | 1.4% | Jun 30, 2026 | Q2 2026 |
| Helix Partners Management LP | 13F | 1.4% | Jun 30, 2026 | Q4 2024 |
| Apollo Management Holdings, L.P. | 13F | 1.4% | Jun 30, 2026 | Q2 2026 |
| Adam Taylor Sullivan | Form 4 | 1.4% | Jul 16, 2026 | — |
| American Century Companies, Inc. | 13F | 1.3% | Jun 30, 2026 | Q4 2025 |
| FIFTH THIRD BANCORP | 13F | 1.2% | Jun 30, 2026 | Q1 2026 |
Core Scientific institutional ownership over time
| Quarter | 13F managers | Share of the company (upper bound) | Value declared | Held by stock pickers |
|---|---|---|---|---|
| Q4 2024 | 307 | 89.4% | $3.5B | 70.3% |
| Q4 2025 | 361 | 113.7% | $5.1B | 65.1% |
| Q2 2026 | 401 | 115.3% | $9.4B | 63.2% |
From SEC Form 13F, every quarter since the end of 2019, read like the current quarter: entities of a house summed, a value contradicting its share count set aside. The share of the company is an upper bound — two managers can declare the same shares — over the shares outstanding at that date.